Why cachexia kills: examining the causality of poor outcomes in wasting conditions.
about
Cardiac cachexia: hic et nuncLoss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatmentUnderstanding cachexia as a cancer metabolism syndromeEfforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention.Muscle wasting: an overview of recent developments in basic research.Moving on up: the Journal of Cachexia, Sarcopenia and Muscle.Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target.Physiology of Mechanotransduction: How Do Muscle and Bone "Talk" to One Another?Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling.STAT3 in the systemic inflammation of cancer cachexia.Pre-dialysis serum sodium and mortality in a national incident hemodialysis cohort.Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease.Intradialytic parenteral nutrition in end-stage renal disease: practical aspects, indications and limits.Muscle wasting disease: a proposal for a new disease classification.Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort.The Obesity Paradox in Kidney Disease: How to Reconcile it with Obesity Management.Evidence for partial pharmaceutical reversal of the cancer anorexia-cachexia syndrome: the case of anamorelin.Dietary protein intake and chronic kidney disease.Muscle wasting in ageing and chronic illness.Exercise capacity, physical activity, and morbidity.Vitamin D, a modulator of musculoskeletal health in chronic kidney disease.Moderator's view: Higher serum bicarbonate in dialysis patients is protective.Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients?Cancer cachexia-when proteasomal inhibition is not enough.North American experience with Low protein diet for Non-dialysis-dependent chronic kidney disease.Changes in body weight and subsequent mortality: are we any closer to knowing how to deal with obesity in ESRD?Czech multicenter research database of severe COPD.Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia.miR-422a suppresses SMAD4 protein expression and promotes resistance to muscle loss.Skeletal Muscle Weakness Is Associated With Both Early and Late Mortality After Acute Respiratory Distress Syndrome.Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes.Subcutaneous Ehrlich Ascites Carcinoma mice model for studying cancer-induced cardiomyopathy.Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease
P2860
Q26744140-71A5D3CD-5455-4BF2-AFC3-CEA4A4051440Q26775254-2B4A1A41-3623-448D-8E37-D10452097745Q28069390-769B1E4B-CCE7-428D-BDDF-5C7333268AE9Q34156932-7764D4BF-D820-4455-BC54-F11A031144E8Q34156942-1CD3CE65-1E98-4C13-8DCD-80C829EB4B1DQ34495485-D93EC2DD-F68C-4036-8C0A-7653BB5E7715Q34556525-4FD3A094-2DFB-4953-8CC4-3F383CE7DF3AQ35025946-A9D0892D-0CA2-4595-84D2-69D5F2C2BC53Q35234328-7FAAACCE-E75E-4553-BBC9-7D6D4AA9FC1AQ35826946-B1C22FD8-3FAA-4BDC-8C1F-3B917D155EF8Q36901910-97A3246C-C0C8-467C-8D02-A5A041441727Q36926918-9B814142-BF62-447B-87B3-EFF5413B28FFQ37734762-1D50E895-302A-4BE7-851B-B3A116107393Q38190040-6B5B043C-CABC-4249-8547-0550F6494DD0Q38268470-F59D24E2-E8E3-4D6F-8AF2-894186D58FE4Q38671285-017FDFEF-A0AB-4E7E-B343-6E2C36C6B7E5Q38821770-01D84DA6-925D-48E5-8FEB-955ED0DE03F9Q38931233-7BEE1066-6E24-4016-97F6-ECD9044C3AABQ38995861-42ED2990-CAD6-40E0-BD86-E5CFD43325F0Q39001205-DA722EF9-560D-4CDE-A2FA-CF66428D34B2Q39090266-103BF29A-997A-48DC-AEE4-C037D5C1E437Q39413414-64DCA156-247C-41E1-A4C8-0002768B7786Q40653167-EF2D54B3-F9E1-45E3-8C68-21A235F91B88Q41829893-E9514D1F-F83A-4E7A-8230-FA30414AF2C8Q41852980-54B08910-6A4E-489A-8F3D-8ECE0AC8A7FBQ42412139-A50B09F9-24FD-4A3D-8270-FF857547753DQ42959018-B167F38B-3539-4DDF-AA4A-70F7D13599D5Q43010454-9A8ACC86-885F-45D2-99EF-A23A865DAB37Q47605033-3CBA2210-D861-4DCE-9F3D-679FC95DE69CQ47688387-83E5CEAE-6169-49CD-8725-A694FB99A866Q47971509-2F7ED29E-492A-4467-9555-EF75160E4190Q50941389-0E7A3536-1D64-45F9-B53B-16B8AE9DD05FQ55002400-018AE660-F1D8-4EDD-A2B8-3496F2C4AC75Q55432588-A2D5B8C2-625D-4FA6-AF72-2A5F1AED7C25Q57771217-656F6E44-9196-47F4-B2E8-6EEA0C27D1EE
P2860
Why cachexia kills: examining the causality of poor outcomes in wasting conditions.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Why cachexia kills: examining the causality of poor outcomes in wasting conditions.
@en
type
label
Why cachexia kills: examining the causality of poor outcomes in wasting conditions.
@en
prefLabel
Why cachexia kills: examining the causality of poor outcomes in wasting conditions.
@en
P2860
P50
P1476
Why cachexia kills: examining the causality of poor outcomes in wasting conditions.
@en
P2093
John J Sim
P2860
P2888
P356
10.1007/S13539-013-0111-0
P577
2013-06-08T00:00:00Z